Doxorubicin potentiates TRAIL cytotoxicity and apoptosis and can overcome TRAIL-resistance in rhabdomyosarcoma cells
Komdeur, R., Meijer, C., Van Zweeden, M., De Jong, S., Wesseling, J., Hoekstra, H., Van der Graaf, W.Language:
english
Journal:
International Journal of Oncology
DOI:
10.3892/ijo.25.3.677
Date:
September, 2004
File:
PDF, 2.27 MB
english, 2004